Back to MARSHALL WACE, LLP

ALNY
7 quarters

Position history for MARSHALL WACE, LLP's holdings in ALNYLAM PHARMACEUTICALS INC

MARSHALL WACE, LLP holds 1.1M shares of ALNY (ALNYLAM PHARMACEUTICALS INC), worth $363.7M as of 2026-Q1. The position was increased (+99.9% shares). ALNY represents 0.4% of MARSHALL WACE, LLP's portfolio.

Current Value

$363.7M

Current Shares

1.1M

Total Value Change

+$346.3M

Total Shares Change

+1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
1.1M
+99.9%
$363.7M0.4%$318.65
60
2025-Q4
Increased
549,922
+8.2%
$218.7M0.2%$397.25
40
2025-Q3
Increased
508,371
+113.1%
$231.8M0.2%$447.49
59
2025-Q2
Decreased
238,573
-11.3%
$77.8M0.1%$322.83
0
2025-Q1
Decreased
268,932
-29.0%
$72.6M0.1%$268.46
0
2024-Q4
Increased
378,649
+496.6%
$89.1M0.1%$236.01
58
2024-Q3
New
63,467
-
$17.5M0.0%$274.91
39

Other major holders of ALNY: FMR LLC, Capital World Investors, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used